228 related articles for article (PubMed ID: 32664877)
1. Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial.
Ni J; Chen H; Chen G; Ji Y; Yi F; Zhang Z; Yang Y; Wu J; Cai X; Shao B; Wang J; Liu Y; Geng D; Qu X; Li X; Wei Y; Ding J; Lü H; Huang Y; Huang Y; Xiao B; Gong T; Cui L;
BMC Neurol; 2020 Jul; 20(1):282. PubMed ID: 32664877
[TBL] [Abstract][Full Text] [Related]
2. [Effects of cinepazide maleate injection on blood pressure in patients with acute ischemic stroke and hypertension].
Chen HS; Yang Y; Ni J; Chen GF; Ji Y; Yi F; Zhang ZB; Wu J; Cai XL; Shao B; Wang JF; Liu YF; Geng DQ; Qu XH; Li XH; Wei Y; Han SG; Zhu RX; Ding JP; Lyu H; Huang YN; Huang YH; Xiao B; Gong T; Yu XF; Cui LY
Zhonghua Nei Ke Za Zhi; 2022 Aug; 61(8):916-920. PubMed ID: 35922216
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.
Zhu Y; Zhang G; Zhao J; Li D; Yan X; Liu J; Liu X; Zhao H; Xia J; Zhang X; Li Z; Zhang B; Guo Z; Feng L; Zhang Z; Qu F; Zhao G
Clin Drug Investig; 2013 Oct; 33(10):755-60. PubMed ID: 23949899
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
6. Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Hu MZ; Zhou ZY; Zhou ZY; Lu H; Gao M; Liu LM; Song HQ; Lin AJ; Wu QM; Zhou HF; Li L; Wang X; Cai YF
Chin J Integr Med; 2020 Jun; 26(6):420-427. PubMed ID: 32361934
[TBL] [Abstract][Full Text] [Related]
7. Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial.
Lai X; Cao K; Kong L; Liu Q; Gao Y;
Trials; 2017 Oct; 18(1):479. PubMed ID: 29037226
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial.
Heo SH; Song J; Kim BJ; Kim H; Chang DI;
Medicine (Baltimore); 2019 Oct; 98(43):e17655. PubMed ID: 31651889
[TBL] [Abstract][Full Text] [Related]
10. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
11. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Grotta J
Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
[TBL] [Abstract][Full Text] [Related]
12. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke.
Huang Y; Guo JW;
Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):417-26. PubMed ID: 20456839
[TBL] [Abstract][Full Text] [Related]
13. BNG-1 in the Recovery of Acute Ischemic Stroke: A phase 2, Double-blind, Placebo-controlled Randomized Trial.
Chang YJ; Lee TH; Chang KC; Liou CW; Ryu SJ
Acta Neurol Taiwan; 2015 Sep; 24(3)():73-81. PubMed ID: 27333830
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
Trials; 2015 Dec; 16():561. PubMed ID: 26654631
[TBL] [Abstract][Full Text] [Related]
15. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
16. Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study.
Chabriat H; Bassetti CL; Marx U; Picarel-Blanchot F; Sors A; Gruget C; Saba B; Wattez M; Audoli ML; Hermann DM
Trials; 2020 Feb; 21(1):136. PubMed ID: 32014032
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial.
Zhang Q; Wang A; Xu Q; Xia X; Tian X; Zhang Y; Li X; Yang X; Wang X; Peng J; Li Y; Liu L; Jin S; Meng X; Zhao X;
JAMA Netw Open; 2023 Aug; 6(8):e2328828. PubMed ID: 37578791
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
[No Abstract] [Full Text] [Related]
19. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
Lang W; Stadler CH; Poljakovic Z; Fleet D;
Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
